We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWPH
4601
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-2,406
Closed -$416K
WDR
4602
DELISTED
Waddell & Reed Financial, Inc.
WDR
-1,405
Closed -$30K
EGOV
4603
DELISTED
NIC Inc
EGOV
-261
Closed -$4K
FPRX
4604
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-296
Closed -$4K
NMCI
4605
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$0 ﹤0.01%
+167
New +$523
GSUM
4606
DELISTED
Gridsum Holding Inc.
GSUM
$0 ﹤0.01%
+25
New +$117
SNDE
4607
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$0 ﹤0.01%
+10
New +$479
DL
4608
DELISTED
China Distance Education Holdings Limited
DL
-100
Closed -$1K
OXFD
4609
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-3,334
Closed -$54K
TCP
4610
DELISTED
TC Pipelines LP
TCP
-401
Closed -$12K
SG
4611
DELISTED
Sirius International Insurance Group, Ltd. Common Share
SG
$0 ﹤0.01%
+7
New +$107
ZAGG
4612
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-12,302
Closed -$181K
CBMG
4613
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
-562
Closed -$11K
CEL
4614
DELISTED
Cellcom Israel, Ltd.
CEL
-371
Closed -$3K
NUM
4615
DELISTED
Nuveen Michigan Quality Municipal Income Fund
NUM
-1,720
Closed -$21K
FBM
4616
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
-9,788
Closed -$122K
PE
4617
DELISTED
PARSLEY ENERGY INC
PE
-100
Closed -$3K
NGHC
4618
DELISTED
National General Holdings Corp
NGHC
-3
Closed
RELV
4619
DELISTED
Reliv International Inc
RELV
$0 ﹤0.01%
+100
New +$476
FORK
4620
DELISTED
Fuling Global Inc
FORK
$0 ﹤0.01%
+2
New +$7
AMAG
4621
DELISTED
AMAG Pharmaceuticals
AMAG
-8,685
Closed -$173K
BITA
4622
DELISTED
Bitauto Holdings Limited
BITA
-2,698
Closed -$62K
ADSW
4623
DELISTED
Advanced Disposal Services Inc
ADSW
-3,446
Closed -$93K
HUSN
4624
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
-244
Closed -$5K
KNOW
4625
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
$0 ﹤0.01%
5

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.